Actionable data,
Better connected

ARWEN is the Actionable Real World Evidence Network, created to help you effortlessly participate in vital research and increase the research output of your hospital – while you stay in full control and ownership of your data.

Join Once, Benefit Continuously

ARWEN: a quickly expanding pan-European network for forward-thinking hospitals, healthcare professionals and researchers with a passion for an ever-growing program of Real-World Evidence research.

Latest updates

New report

New Report: ‘On the Horizon’ – providing actionable insights into upcoming innovative medicines and their costs:

ARWEN launches first study protocols

First ARWEN study protocols for Oncology (Solid & Liquid tumours) and Immunology are launched. To enrol in studies, click the button below.

We have the answer to your questions

“What are the clinical results in practice?” Physician
“What are patient outcomes in practice?” Chief Medical Officer
“What are the costs linked to the administration of drugs?” Chief Financial Officer
“How is a drug used in daily practice?” Pharmacist
ARWEN logo

Actionable Real World Evidence Network

A standardised,
fit-for-purpose platform

We offer a platform to connect supply and demand of drug-related research questions on our network.

With high-class
extraction support

We support you in extraction, validation and linkage of data to keep additional effort and costs to a minimum.

That unlocks the value in your data

We help you to participate in more research and increase financial rewards and academic returns.

Enabling meaningful

We enable you to collaborate with regulatory parties, insurance companies and pharma to do more RWE based research.

ARWEN ensures continuous control of your data

Your data is yours

You are not our product, and neither is your data. We are data analysts, not data brokers.

Your data is safe

The privacy and security of your data always come first. We hold ourselves to the same standards as you do.

Your data is valuable

How you unlock the value in your data, is your choice. We work to turn data into value, in full transparency.

Your data is vital

Your data holds the potential to fast-track crucial research. We are proud to be a highly respected and trusted 3rd party.

Join running studies and enroll in new projects

Drug use &
epidemiology analysis

Main Qs answered

How many and what types of patients are using a drug? How many are eligible?

Examples of typical projects

  • Epidemiology study
  • Patient group analysis and segmentation
  • (Medicine) treatment pattern analysis

Standard of care &
patient pathway analysis

Main Qs answered

How are patients treated in the hospitals?

Examples of typical projects

  • Analysis of patient pathways
  • Treatment adherence to guidelines
  • Segmentation of patient groups by treatment modality
  • Identification of improvement areas

Drug impact analysis on outcomes & costs

Main Qs answered

What is / will be the impact of a drug on the hospital (pathway, costs, outcomes, etc.)?

Examples of typical projects

  • Impact of drugs on hospital costs, efficiency and patient outcomes
  • Horizon scanning (analysis of impact of upcoming drugs)
  • Drug effectiveness comparison

Frequently asked questions

What is the added value of being a member of ARWEN?

ARWEN makes your Real-World Data (RWD) more actionable: increasing the research output of your hospital in a way that is fast, scalable and transparently generates revenues. With ARWEN collecting, standardising and analysing RWD to participate in more academically & financially rewarding research, shouldn’t have to be a struggle.

What is the added value of becoming a launching partner of ARWEN?

As a launching partner, you will get the first pick on which studies and programmes to join. This is beneficial given most studies and programmes have limited spots.

What does actionable mean in ARWEN?

We don’t just help hospitals easily apply and join Real-World Evidence (RWE) research opportunities, but we enable the research itself, solving the major pain points that are hampering current studies.

We aim to speed up the generation of insights in the real-world to provide actionable insights to improve healthcare.

the network for forward thinking healthcare providers